pharma review

Pharmalive - The Pulse of the Pharmaceutical Industry
Corporate Access Log In
Search Criteria: Search In:

Visit http://www.knowledgedriven.com/
Conferences



Business


Marketing and Advertising


Therapeutics


R and D Directions


FDA News


Conferences


People


Business Strategy
Financial News
Generics
Legal Actions
Patent Issues
Agency News
Electronic Marketing
Product Marketing News
Cardiovascular
Oncology
Pain & Inflammation
Central Nervous System
Infectious Disease
Contract Research Business
Drug Approvals
Drug Discovery
Drugs In Development
eR&D
Filed For Approval
Trial Results
Regulatory Actions
Warnings
FDA Policy
Investment Banking Healthcare
Medical/Professional


Pharma Blog Review By Chris Truelove
Meet Our Editors
Happy new year, sort of
January 15, 2010 – 7:15 pm by Chris

Yes, the Pharma Blog Week in Review is back. I had to take a break from it over the holidays; I even became so silent on Twitter that I had a few folks ask me if I was all right. But I knew I’d get back into the swing of things in the new year.
And [...]

Posted in Uncategorized | No Comments »
J&J job cuts kick off week
November 6, 2009 – 5:35 pm by Chris

It’s a mixed bag this week in pharma industry news (much like that sack of your kids hauled home from their trick-or-treating, for every KitKat, there’s a bag of candy corn). Some of the notable items: Johnson & Johnson announced the company would be reducing its headcount by 7% (and Eli Lilly also [...]

Posted in Uncategorized | No Comments »
For Halloween, some bloggy treats (no tricks)
October 30, 2009 – 4:04 pm by Chris

Halloween is tomorrow, but for the pharmaceutical industry, the real “party” will be November’s two-day meeting on social media use, sponsored by FDA. Everyone is hoping the hearing will yield a treat (in the form of a workable guidance on social media) and not tricks (in the form of FDA remaining inscrutable and issuing warning [...]

Posted in Uncategorized | No Comments »
Pharma still uneasy about getting social
October 23, 2009 – 3:51 pm by Chris

This week was full and frantically busy, and I am not just talking about the three days I drove back and forth to Bridgewater, N.J., for ExL Pharma’s Digital Pharma conference (if you want the quick lowdown on what happened there, you can find the Tweets, from me and many others, under the hashtag #DigPharm). [...]

Posted in Uncategorized | No Comments »
Pfizer pfuels burst of blogger speculation
October 16, 2009 – 4:31 pm by Chris

The week ended in a big way, as Pfizer’s acquisition of Wyeth became final and FDA approved GlaxoSmithKline’s Cervarix vaccine for cervical cancer. Also, debate continued about the healthcare reform bill passed by the Senate Finance Committee last week. And fortunately for the industry, no recent bombs about ghostwriting or other scandals hit the air. [...]

Posted in Uncategorized | No Comments »
Catching up, after vacation
October 9, 2009 – 5:29 pm by Chris

Now that I’m back in the office from my Boston vacation (and a very interesting visit last Monday with Jeff Porter, Tim Wright, and Mark Fishman of Novartis Institutes for Biomedical Research, which I will be writing about in January’s R&D Directions), I have some stuff to catch up on. Abbott is buying Solvay’s pharmaceutical [...]

Posted in Uncategorized | No Comments »
Previous Entries

Inc Research
Ask The Experts

MedAdNews
Are the upcoming FDA public hearings on the use of the Internet ...
I’m assisting a co-worker with a case study in which one of the ...
As I manage a community outreach program for a large hospital ...

R&D Directions
Are the benefits of integrating IVR systems with other study ...
Webcasts

MedAdNews
Views on Patient Adherence
Tuesday, January 12, 2010 2:00 PM EDT
Register

Improving Compliance Through Master Data Management and an Aggregate Spend Solution
Monday, September 21, 2009 2:00 PM EDT
View Webinar

R&D Directions
Investigator Site Solutions for Clinical Trials
Thursday, September 17, 2009
View Webinar
Special Reports
purchase subscription editorial calendar
renew subscription advertise
order back issues feedback
subscriber registration site license

purchase subscription editorial calendar
renew subscription advertise
order back issues feedback
subscriber registration site license
Top 20 Pipelines 2009

This PharmaLive.com Special Report provides expert analysis of the top pharma and biotech pipelines detailing products in development and awaiting approval. Insight into each company’s R&D organization includes corporate R&D philosophy and goals, therapeutic areas of focus, promising products, and recent R&D news.

Get valuable insight into successful discovery and development strategies as well as potentially competitive products.

$420 introductory rate expires 1/5/2010.

Learn More
Analytical Reports News Archive
Site License/RSS eKnowledgeBase
Only on PharmaLive.com
Medical education to fill the credibility gap
Ad agencies decode behavior in women’s health
Q&A: Patent landscape faces change
Q&A: Sanofi transforms R&D approach as patent cliff looms

Pharma Blog Review
J&J job cuts kick off week

MedAdNews Insider
Autoinjector Technology in Autoimmune
Peril and promise of healthcare reform

R&D Directions Insider
StudyOptimizer gets patient enrollment programs back on track
Emerging markets push has CRO at ready

*
*
Recent Comments
o David Avitabile:It has certainly been an inter
o EileenOBrien:Thanks for attending the first
o Faisal Roohi:The Levine vs Wyeth case is li
o WendyB:Hi Chris! Thanks so much for t
o Faisal Roohi:Vioxx, Zyprexa and now Neuront
o Sunil S Chiplunkar:I thank you for your interest
o jcarlson:Chris, thanks for compiling th
o Faisal Roohi:The race for the next blockbus
o eiobri:It's great that the enewslette
o Chris:Thanks Mark! I have to say, if
*
Recent Post
o Another day, another roundup
o Of robots and pharma …
o (tap tap tap) Is this thing on?
o Hot times, hot schedule
o It’s just another day …
o Finally at BIO 2008
o Bio 2008, part 2
o Another battle in the Green Mountain State
o Greetings from DIA
o And now back to the blogs …
*
Pages
o About Chris Truelove
*
Archives
o January 2010
o November 2009
o October 2009
o September 2009
o August 2009
o July 2009
o June 2009
o May 2009
o April 2009
o March 2009
o February 2009
o January 2009
o December 2008
o November 2008
o October 2008
o September 2008
o August 2008
o July 2008
o June 2008
*
Categories
o Uncategorized (76)
*
o Register
o Log in


about us | advertise | contact us | home
terms of use | privacy | copyright | site map ©2010 Canon Communications Pharmaceutical Media Group